We use cookies for a better user experience. Read our Privacy Policy

I Agree

Coronary Stents Market

Coronary Stents Market (Product Type: Bare Metal Stents, Drug Eluting Stents, and Bio-absorbable Stents) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Coronary Stents Market Outlook 2028

  • The global coronary stents market was valued at US$ 10.1 Bn in 2020
  • It is estimated to expand at a CAGR of 12.9% from 2021 to 2028
  • The global coronary stents market is expected to reach the value of US$ 25.7 Bn by the end of 2028

Analysts’ Viewpoint on Coronary Stents Market Scenario

There is an increasing demand for coronary stents from the healthcare industry due to rapidly rising cardiovascular diseases globally. It has been found that majority of deaths were caused by heart attack, high systolic blood pressure etc. in the past few years in several developing nations. The growing incidences of coronary artery diseases (CADs), along with rising obesity issues across the globe is fueling the coronary stents market growth. However, high cost of coronary stents, lack of reimbursement policies in some regions, and complications such as in-stent restenosis or thrombosis are major factors restraining the global coronary stents market. Novel technologies in clinical trials to address the unmet needs and emerging economies such as China, India, Brazil, and others are likely to offer significant opportunities to manufacturers operating in the coronary stents market.

Increase in Demand Due to Rise in Prevalence of Cardiovascular Diseases

The growing incidence of cardiovascular disorders in people across the globe is a major factor driving the coronary stents market during the forecast period. Coronary stents are tubes placed in the coronary artery to clear artery blockages or coronary artery stenosis. They are utilized in a procedure called percutaneous coronary intervention (PCI) or coronary angioplasty. This procedure is a minimally invasive procedure to treat stenosis or narrowing of the coronary arteries. Technology plays an indispensable role in the global coronary stents market. Manufacturers have been undertaking rigorous research and development initiatives to develop nascent products that are functionally superior to their previous versions.

Changes in lifestyle and need of controlling rapidly rising obesity rate are major factors for the treatment of cardio vascular disease (CVD). Percutaneous coronary intervention has become a standard treatment option preferred across the globe for CVD. Increase in awareness about the technological innovations in interventional cardiology and cost effectiveness of the procedure propel stents production.

Request a sample to get extensive insights into the Coronary Stents Market

Stringent Regulations for Product Approvals in Developing Nations

The approval of medical devices is considered to be expensive. Coronary stents fall under the category III devices of the U.S. FDA. These devices require submission and approval of pre-market approval (PMA) application prior to commercial marketing in the U.S. The requirements of clinical and pre-clinical data for stents engage the sponsor and manufacturer for a long period of time. Resources of manufacturers and investors such as time and money are spent on conducting safety testing and clinical pharmacology and toxicology testing of drug substance in case of DES. The FDA’s regulatory procedures are comparatively time-consuming as compared to that of EMA. Thus, prolonged procedures of drug approval by regulatory authorities in the U.S. deter manufacturers from opting for development and commercialization of stents.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Drug Eluting Stent to be Highly Lucrative Segment

Advancements in the coronary stent technology are expected to augment the market during the forecast period. The drug eluting stent segment is expected to account for a major market share in the upcoming years. There is an increasing risk of stent thrombosis in patients after stopping the antiplatelet therapy. The management of CAD has improved to advances in the drug eluting stent (DES) technology. The advanced technology can be efficiently used to treat patients with coronary artery diseases. New materials are being developed for the treatment such as biodegradable metals, etc. Technological advancements in coronary stents and lucrative presence of manufacturers are driving the global coronary stents market growth.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Coronary Stents Market

North America Coronary Stents Market to Expand at Rapid Pace

North America is expected to dominate the global coronary stents market, followed by Europe and Asia Pacific nations such as Japan and China. CVDs are listed as a major cause of mortality across the world, responsible for one in every three deaths in the U.S. The occurrence of restenosis after angioplasty procedure boosts the adoption of novel stents, such as drug-eluting and bioresorbable, which are known to drastically reduce the frequency of restenosis. This factor boosts the demand for coronary stents in North America. High geriatric population, lifestyle changes leading to obesity and related health complications, and advent of advanced technologies such as bio-absorbable and next generation stents are major factors driving the North America coronary stents market.

Coronary Stents Market: Overview

  • According to Transparency Market Research’s latest report on the global coronary stents market for the historical period 2017–2019 and forecast period from 2021 to 2028, rise in prevalence of coronary artery diseases (CADs) and increase in global obesity rate are projected to drive the global coronary stents market during the forecast period

Rise in Prevalence of Cardiovascular Diseases: Key Driver

  • Cardiovascular diseases (CVD) overtook cancer as the leading cause of chronic disease morbidity and mortality in the 20th Century. It has peaked and begun to fall in many countries, while it is rising in developing countries. Risk factors, sociocultural changes, and medical care all play a role in understanding these disease patterns.
  • According to the World Health Organization, 17.9 million people succumbed to CVDs in 2019, constituting 32% of all global deaths. Around 85% of these deaths were caused by a heart attack or a stroke.
  • More than three-quarters of CVD deaths occur in low- and middle-income countries. In 2019, non-communicable diseases claimed the lives of 17 million people under the age of 70, accounting for 38% of all premature deaths.
  • High systolic blood pressure and smoking are the first and second leading risk factors for years of life lost globally in 2019. In the same year, the first and second leading years lived with disability and injury risk factors were high fasting plasma glucose and high body mass index.

Improvement in Coronary Stents Technology Boosts Market Growth

  • Coronary stent technology has progressed from a mechanical solution to abrupt vessel closure and elastic recoil after simple balloon angioplasty to a vector for local drug delivery and modification of coronary plaque pathophysiology. The introduction of drug-eluting stents (DES) has significantly reduced restenosis, but there is growing concern about the risk of late stent thrombosis, particularly after stopping antiplatelet therapy.
  • Management of coronary artery disease has improved to advances in drug eluting stent (DES) technology. They improve long-term patency rates by inhibiting restenosis through the controlled release of an antiproliferative agent, such as Paclitaxel, after deployment.
  • In the field of stent technology for treating patients with coronary artery disease, there has been a rapid technological advancement. As potential materials for the next generation of cardiovascular system treatment are developed, the use of biodegradable metals as implants will be revolutionized. Hence, enhancement in the coronary stents technology is expected to augment the market during the forecast period.

Stringent Regulatory Approvals to Hamper Market

  • Stringent regulatory approvals for coronary stents is likely to hamper market growth. The stringent regulatory environment could act as a restraint of the global coronary stents market over the next few years. Various governments and organizations establish guidelines and rules for the safer and more effective use of stents.
  • The European Association of Percutaneous Cardiovascular Interventions (EAPCI) provides clinical and non-clinical stent guidelines. Additionally, before approving stents, the FDA conducts a thorough systemic review of the literature as well as pre-clinical trials in human.
  • The Office of Combination Products (OCP) has published regulations for surgeons and physicians to use drug-eluting stents. These stringent rules for the use of stents are projected to hamper the growth of the global market.

Coronary Stents Market: Competition Landscape

  • This report profiles major players in the global coronary stents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global coronary stents market is competitive, with the top 10 players accounting for major share of the market and companies focusing on research & development to produce better pharmaceutical and vaccine products for the existing diseases
  • Leading players operating in the global coronary stents market are
    • Abbott Laboratories Inc.
    • Boston Scientific Corporation
    • Medtronic Inc.
    • Johnson & Johnson
    • Terumo Corporation
    • B. Braun Melsungen AG
    • C. R. Bard Inc.
    • Cook Medical Inc.
    • AMG International GmbH
    • Biotronik SE & Co. KG
    • Stentys SA
    • and MicroPort Scientific Corporation
    • among others

Coronary Stents Market: Key Developments

  • Key players in the global coronary stents market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global coronary stents market. A few expansion strategies adopted by players operating in the global coronary stents market are:
  • In September 2021, the U.S. Food and Drug Administration (FDA) approved BIOTRONIK's Orsiro Mission bioabsorbable polymer drug-eluting stent system in September 2021 (BP-DES)
  • In August 2020, Boston Scientific Corporation's SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System obtained FDA clearance
  • In January 2016, Abbott paid US$ 25 Bn for St. Jude Medical, Inc. (U.S.), a maker of heart failure, atrial fibrillation, and cardiac rhythm management devices. The acquisition enabled Abbott to boost its coronary intervention product offerings and expand its foothold in the cardiovascular devices industry.
  • In May 2016, Boston Scientific and Mayo Clinic (USA) teamed up to share intellectual property and accelerate the development of medical devices
  • The report on the global coronary stents market discusses individual strategies followed by company profiles of manufacturers of coronary stents devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global coronary stents market.

Coronary Stents Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 10.1 Bn

Market Forecast Value in 2028

US$ 25.7 Bn

Growth Rate (CAGR)

12.9%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Bare Metal Stents
    • Drug Eluting Stents
    • Bio-absorbable Stents

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Johnson & Johnson
  • Terumo Corporation
  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Cook Medical, Inc.
  • AMG International GmbH
  • Biotronik SE & Co. KG
  • Stentys SA
  • MicroPort Scientific Corporation
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Coronary Stents Market – Segmentation

Product Type
  • Bare Metal Stents
  • Drug Eluting Stents
  • Bio-absorbable Stents
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of coronary stents market?

Coronary stents market is expected to reach the value of US$ 25.7 Bn by the end of 2028

What is the anticipated CAGR of the coronary stents market in the forecast period?

Coronary stents market is estimated to expand at a CAGR of 12.9% from 2021 to 2028

What are the key driving factors for the growth of the coronary stents market?

Coronary stents market is driven by growing incidence of cardiovascular disorders in people across the globe

Which is the rising prominent segment in the coronary stents market?

The drug eluting stent segment is expected to account for a major coronary stents market share in the upcoming years

Who are the key players in the global coronary stents market?

Key players in the global coronary stents market include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Coronary Stents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Coronary Stents Market Analysis and Forecast, 2017–2028

5. Key Insights

    5.1. Technological Advancements

    5.2. Key Mergers & Acquisitions 

    5.3. Regulatory Scenario by Region/globally

    5.4. COVID-19 Pandemics Impact on Industry

6. Global Coronary Stents Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2028

        6.3.1. Bare Metal Stents

        6.3.2. Drug Eluting Stents

        6.3.3. Bio-absorbable Stents

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Coronary Stents Market Analysis and Forecast, by Region

    7.1. Key Findings

    7.2. Market Value Forecast, by Region

        7.2.1. North America 

        7.2.2. Europe 

        7.2.3. Asia Pacific 

        7.2.4. Latin America 

        7.2.5. Middle East & Africa 

    7.3. Market Attractiveness Analysis, by Region

8. North America Coronary Stents Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. Market Value Forecast, by Product Type, 2017–2028

        8.2.1. Bare Metal Stents

        8.2.2. Drug Eluting Stents

        8.2.3. Bio-absorbable Stents

    8.3. Market Value Forecast, by Country, 2017–2028

        8.3.1. U.S. 

        8.3.2. Canada 

    8.4. Market Attractiveness Analysis 

        8.4.1. By Product Type

        8.4.2. By Country

9. Europe Coronary Stents Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product Type, 2017–2028

        9.2.1. Bare Metal Stents

        9.2.2. Drug Eluting Stents

        9.2.3. Bio-absorbable Stents

    9.3. Market Value Forecast, by Country/Sub-region, 2017–2028

        9.3.1. Germany 

        9.3.2. U.K. 

        9.3.3. France 

        9.3.4. Italy 

        9.3.5. Spain 

        9.3.6. Rest of Europe 

    9.4. Market Attractiveness Analysis 

        9.4.1. By Product Type

        9.4.2. By Country/Sub-region

10. Asia Pacific Coronary Stents Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2028

        10.2.1. Bare Metal Stents

        10.2.2. Drug Eluting Stents

        10.2.3. Bio-absorbable Stents

    10.3. Market Value Forecast, by Country/Sub-region, 2017–2028

        10.3.1. China 

        10.3.2. Japan 

        10.3.3. India 

        10.3.4. Australia & New Zealand 

        10.3.5. Rest of Asia Pacific 

    10.4. Market Attractiveness Analysis 

        10.4.1. By Product Type

        10.4.2. By Country/Sub-region

11. Latin America Coronary Stents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2028

        11.2.1. Bare Metal Stents

        11.2.2. Drug Eluting Stents

        11.2.3. Bio-absorbable Stents

    11.3. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.3.1. Brazil 

        11.3.2. Mexico 

        11.3.3. Rest of Latin America 

    11.4. Market Attractiveness Analysis 

        11.4.1. By Product Type

        11.4.2. By Country/Sub-region

12. Middle East & Africa Coronary Stents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2028

        12.2.1. Bare Metal Stents

        12.2.2. Drug Eluting Stents

        12.2.3. Bio-absorbable Stents

    12.3. Market Value Forecast, by Country/Sub-region, 2017–2028

        12.3.1. GCC Countries 

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa 

    12.4. Market Attractiveness Analysis 

        12.4.1. By Product Type

        12.4.2. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player - Competition Matrix (by tier and size of companies)

    13.2. Market Share Analysis, by Company, 2020

    13.3. Company Profiles

        13.3.1. Abbott Laboratories

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.1.2. Financial Analysis

            13.3.1.3. Growth Strategies

            13.3.1.4. SWOT Analysis

        13.3.2. Boston Scientific Corporation

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.2.2. Financial Analysis

            13.3.2.3. Growth Strategies

            13.3.2.4. SWOT Analysis

        13.3.3. Medtronic, Inc.

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.3.2. Financial Analysis

            13.3.3.3. Growth Strategies

            13.3.3.4. SWOT Analysis

        13.3.4. Johnson & Johnson 

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.4.2. Financial Analysis

            13.3.4.3. Growth Strategies

            13.3.4.4. SWOT Analysis

        13.3.5. Terumo Corporation

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.5.2. Financial Analysis

            13.3.5.3. Growth Strategies

            13.3.5.4. SWOT Analysis

        13.3.6. B. Braun Melsungen AG

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.6.2. Financial Analysis

            13.3.6.3. Growth Strategies

            13.3.6.4. SWOT Analysis 

        13.3.7. C. R. Bard, Inc.

            13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.7.2. Financial Analysis

            13.3.7.3. Growth Strategies

            13.3.7.4. SWOT Analysis

        13.3.8. Cook Medical, Inc.

            13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.8.2. Financial Analysis

            13.3.8.3. Growth Strategies

            13.3.8.4. SWOT Analysis

        13.3.9. AMG International GmbH

            13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.9.2. Financial Analysis

            13.3.9.3. Growth Strategies

            13.3.9.4. SWOT Analysis

        13.3.10. Biotronik SE & Co. KG 

            13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.10.2. Financial Analysis

            13.3.10.3. Growth Strategies

            13.3.10.4. SWOT Analysis

        13.3.11. Stentys SA

            13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.11.2. Financial Analysis

            13.3.11.3. Growth Strategies

            13.3.11.4. SWOT Analysis

        13.3.12. MicroPort Scientific Corporation

            13.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.12.2. Financial Analysis

            13.3.12.3. Growth Strategies

            13.3.12.4. SWOT Analysis

List of Tables 

Table 01: Global Coronary Stents Market Value (US$ Mn) Forecast, by Product Type, 2017–2028

Table 02: Global Coronary Stents Market Value (US$ Mn) Forecast, by Region, 2017–2028

Table 03: North America Coronary Stents Market Value (US$ Mn) Forecast, by Country, 2017–2028

Table 04: North America Coronary Stents Market Value (US$ Mn) Forecast, by Product Type, 2017–2028

Table 05: Europe Coronary Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 06: Europe Coronary Stents Market Value (US$ Mn) Forecast, by Product Type, 2017–2028

Table 7: Asia Pacific Coronary Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 8: Asia Pacific Coronary Stents Market Value (US$ Mn) Forecast, by Product Type, 2017–2028

Table 9: Latin America Coronary Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 10: Latin America Coronary Stents Market Value (US$ Mn) Forecast, by Product Type, 2017–2028

Table 11: Middle East & Africa Coronary Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 12: Middle East & Africa Coronary Stents Market Value (US$ Mn) Forecast, by Product Type, 2017–2028

List of Figures

Figure 01: Global Coronary Stents Market Value Share Analysis, by Product Type, 2021 and 2028

Figure 02: Global Coronary Stents Market Attractiveness Analysis, by Product Type, 2021–2028

Figure 03: North America Coronary Stents Market Value (US$ Mn) Forecast, 2017–2028

Figure 04: North America Coronary Stents Market Value Share Analysis, by Country, 2021 and 2028

Figure 05: North America Coronary Stents Market Attractiveness Analysis, by Country, 2021–2028

Figure 06: North America Coronary Stents Market Value Share Analysis, by Product Type, 2021 and 2028

Figure 07: North America Coronary Stents Market Attractiveness Analysis, by Product Type, 2021–2028

Figure 08: Europe Coronary Stents Market Value (US$ Mn) Forecast, 2017–2028

Figure 09: Europe Coronary Stents Market Value Share Analysis, by Country/Sub-region, 2021 and 2028

Figure 10: Europe Coronary Stents Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 11: Europe Coronary Stents Market Value Share Analysis, by Product Type, 2021 and 2028

Figure 12: Europe Coronary Stents Market Attractiveness Analysis, by Product Type, 2021–2028

Figure 13: Asia Pacific Coronary Stents Market Value (US$ Mn) Forecast, 2017–2028

Figure 14: Asia Pacific Coronary Stents Market Value Share Analysis, by Country/Sub-region, 2021 and 2028

Figure 15: Asia Pacific Coronary Stents Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 16: Asia Pacific Coronary Stents Market Value Share Analysis, by Product Type, 2021 and 2028

Figure 17: Asia Pacific Coronary Stents Market Attractiveness Analysis, by Product Type, 2021–2028

Figure 18: Latin America Coronary Stents Market Value Share Analysis, by Country/Sub-region, 2021 and 2028

Figure 19: Latin America Coronary Stents Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 20: Latin America Coronary Stents Market Attractiveness Analysis, by Product Type, 2021–2028

Figure 21: Middle East & Africa Coronary Stents Market Value Share Analysis, by Country/Sub-region, 2021 and 2028

Figure 22: Middle East & Africa Coronary Stents Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 23: Middle East & Africa Coronary Stents Market Attractiveness Analysis, by Product Type, 2021–2028

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

274

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved